Trials / Completed
CompletedNCT06428318
Diagnostic Value of the Biofire®in Community Acquired Pneumonia
Diagnostic Value of the Biofire® Filmarray Pneumonia Panel Compared to Conventional Sputum Culture in Critically il Patients With Pneumonia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to determine the impact value of the BioFire FilmArray Pneumonia panel compared to conventional sputum culture in critically ill patients with pneumonia.
Detailed description
the BioFire® FilmArray Pneumonia Panel (BFPP) emerges as a promising candidate for a rapid and multifaceted diagnostic approach. This study compare the diagnostic accuracy, turnaround time, and impact on antibiotic management decisions of BFPP versus conventional sputum culture in critically ill patients admitted to the ICU with suspected pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Conventional Sputum culture | Sputum culture was done to patients and they received Antibiotics According to its results |
| DIAGNOSTIC_TEST | BioFire Pneumonia Panel (BFPP) | BioFire Pneumonia Panel (BFPP) was done to patients and they received Antibiotics According to its results |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2024-05-24
- Last updated
- 2024-05-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06428318. Inclusion in this directory is not an endorsement.